Paritaprevir is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It belongs to a class of drugs known as direct-acting antiviral (DAA) agents, which work by blocking specific proteins that the virus needs to reproduce. Paritaprevir is typically used in combination with other medications, such as ritonavir, ombitasvir, and dasabuvir. It is most effective when used to treat genotype 1a or 1b HCV, however, it may also be useful for other genotypes. Paritaprevir can help reduce the amount of virus in the body and may lead to a cure.
Paritaprevir is an antiviral medication used in combination therapy to treat chronic hepatitis C virus (HCV) infection. Here's a breakdown of its key aspects:
How it works:
- Paritaprevir belongs to a class of drugs called non-nucleoside inhibitors of the hepatitis C virus (HCV) NS3/4A protease. HCV replicates (makes copies of itself) using a specific enzyme called NS3/4A protease. Paritaprevir inhibits this enzyme, hindering the virus's ability to replicate and reducing its spread in the body [1].
Use in combination therapy:
- Paritaprevir is not typically used alone. It's most effective when combined with other antiviral medications, such as ritonavir (Norvir) and other drugs, depending on the specific HCV genotype (strain) and treatment regimen [1, 2].
Dosage and administration:
- Paritaprevir is usually available in a co-formulated tablet with another medication, ombitasvir (Technivie), under the brand name Technivie. The dosage and duration of treatment depend on various factors like your HCV genotype, liver function, and other medical conditions. It's crucial to follow your doctor's instructions carefully [1].
Side effects:
- Paritaprevir, used in combination with other medications, can cause some side effects, including [1, 2]:
- Fatigue
- Nausea
- Headache
- Diarrhea
- Insomnia
- Skin rash
Important considerations:
- Drug interactions: Paritaprevir can interact with other medications, including some cholesterol-lowering drugs and antiarrhythmic medications. Inform your doctor about all medications you take before starting paritaprevir therapy.
- Liver function monitoring: Regular blood tests are needed to monitor your liver function while taking paritaprevir, as it can affect liver enzymes in some cases.
- Not a cure: Paritaprevir, in combination therapy, aims to achieve sustained virologic response (SVR), meaning the HCV virus is undetectable in the blood for a certain period, indicating successful treatment. However, it doesn't necessarily equate to a complete cure for everyone.